Rated by clients for the regulatory capabilities across the team, Osborne Clarke acts for a broad client base which notably includes Coopervision, OncoDNA, and Medi-market. The ‘excellent’ Hadrien Chef leads the team and has vast corporate expertise, regularly assisting medical diagnostic, medtech, and biotech companies with financings and reorganisations. Praised for his ‘sharp edge’, Vladimir Murovec is known for his deep regulatory knowledge, particularly in relation to digital health, pharma, and medical device issues.
Testimonials
Collated independently by Legal 500 research team.
‘They consistently work as an integrated team, involving the right people at the right time. The practice got a solid boost with the arrival of Vladimir Murovec and are now a fully-fledged medtech and pharma practice with top-notch regulatory capabilities. It is good to see their practice flourish from a local Belgian provider to a truly international service offering with standout EU regulatory competence.’
‘Hadrien Chef stands out as an excellent lawyer.’
‘Vladimir Murovec is able to admirably handle both domestic mandates with a purely local element and global EU projects. Vladimir is quite sharp, but keeps it casual with the team and is always happy to brainstorm about potential projects, which is nice and refreshing; he's become a reference in Regulatory and Compliance in the EU Life sciences space.’
‘Vladimir Murovec is very committed, provides to-the-point information and high quality output. ’
‘Hadrien Chef has a global overview and understanding, providing preventative advice. He is highly flexible and available.’
‘What sets OC Brussels apart is their knack for seamless teamwork. In recent years, they've become a go-to provider for multiple global pharmaceutical businesses with top regulatory capabilities.’
‘I truly appreciate Vladimir Murovec's versatility, he navigates local and global assignments with ease, whether it's handling national investigations or diving into global-scale projects connected to EMA procedures or European Commission approvals.’
‘Vladimir Murovec has that sharp edge when it comes to regulatory and compliance in the EU Life Sciences arena. He keeps things laid-back and is easy to approach which sets him apart as a go-to lawyer in the field.’
Key clients
- Afflelou Group
- Alnylam Pharmaceuticals
- Bepharbel Manufacturing
- Bone Therapeutics (BioSenic)
- Coopervision
- Epstein, Becker & Green
- Medi-Market
- Novo Nordisk
- OncoDNA
- Sunrise
Work highlights
- Advised BioSenic on its reverse merger with French Company Medsenic, in addition to advising on the client's IP, commercial and overall ECM needs.
- Advised Sunrise on its recent €17m fundraising, led by Kurma Partners and the EIC fund, its subsequent acquisition of strategic assets in France and the US from French company Dreem SAS, and its partnerships, distribution and regulatory strategy to support the roll out of its sleep apnoea test in Europe and the American market.
- Advised a global pharmaceutical company on its dealings with a local biobank for the storage and shipment of plasma-derived products across the European Union.
Lawyers
Practice head
The lawyer(s) leading their teams.
Hadrien Chef